<DOC>
	<DOCNO>NCT00367783</DOCNO>
	<brief_summary>The purpose study determine whether CP-741,952 effective treatment obesity determine 12 week safety toleration .</brief_summary>
	<brief_title>Safety , Toleration Efficacy CP-741,952 Treatment Obesity</brief_title>
	<detailed_description>Following review preliminary data complete study A7081004 , development program CP-741,952 terminate 15 March 2007 . Primary reason program termination include lack significant efficacy dos investigate increased incidence mild moderate elevation serum transaminase , primarily alanine aminotransferase ( ALT ) , liver fat content , treat compare placebo subject . A synopsis create include great detail finding .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<criteria>BMI 3040 kg/m2 Women childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>